Soleus Capital Management, L.P. Organogenesis Holdings Inc. Transaction History

Soleus Capital Management, L.P.

$1.21 Billion
Q1 2025

A detailed history of Soleus Capital Management, L.P. transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 12,478,351 shares of ORGO stock, worth $35.9 Million. This represents 4.46% of its overall portfolio holdings.

Number of Shares

12,478,351

Previous 12,484,876 0.05%

Holding current value

$35.9 Million

Previous $40 Million 34.93%

% of portfolio

4.46%

Previous 2.78%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$2.89 - $6.21 $18,857 - $40,520	-6,525 Reduced 0.05%	12,478,351 $53.9 Million
Q4 2024 Feb 14, 2025	BUY	$2.77 - $4.43 $1.79 Million - $2.86 Million	645,000 Added 5.45%	12,484,876 $40 Million
Q3 2024 Nov 14, 2024	BUY	$2.42 - $3.24 $776,631 - $1.04 Million	320,922 Added 2.79%	11,839,876 $33.9 Million
Q2 2024 Aug 14, 2024	BUY	$2.28 - $3.03 $4.44 Million - $5.9 Million	1,945,756 Added 20.33%	11,518,954 $32.3 Million
Q1 2024 May 15, 2024	BUY	$2.61 - $4.49 $1.59 Million - $2.74 Million	610,198 Added 6.81%	9,573,198 $27.2 Million
Q4 2023 Feb 14, 2024	SELL	$1.97 - $4.21 $6.57 Million - $14 Million	-3,333,163 Reduced 27.11%	8,963,000 $36.7 Million
Q3 2023 Nov 14, 2023	BUY	$2.34 - $4.43 $1.33 Million - $2.52 Million	568,100 Added 4.84%	12,296,163 $39.1 Million
Q2 2023 Aug 14, 2023	BUY	$1.9 - $4.3 $3.56 Million - $8.06 Million	1,875,000 Added 19.03%	11,728,063 $38.9 Million
Q1 2023 May 15, 2023	BUY	$1.89 - $2.93 $4.71 Million - $7.3 Million	2,490,000 Added 33.82%	9,853,063 $21 Million
Q4 2022 Feb 14, 2023	BUY	$2.48 - $3.43 $2.17 Million - $3 Million	874,000 Added 13.47%	7,363,063 $19.8 Million
Q3 2022 Nov 14, 2022	BUY	$3.14 - $6.43 $3.78 Million - $7.73 Million	1,202,896 Added 22.76%	6,489,063 $21 Million
Q2 2022 Aug 15, 2022	BUY	$4.74 - $8.15 $13 Million - $22.4 Million	2,746,000 Added 108.1%	5,286,167 $25.8 Million
Q1 2022 May 16, 2022	BUY	$6.47 - $9.57 $3.5 Million - $5.18 Million	541,080 Added 27.07%	2,540,167 $19.4 Million
Q4 2021 Feb 14, 2022	BUY	$9.02 - $13.5 $12.3 Million - $18.3 Million	1,359,200 Added 212.41%	1,999,087 $18.5 Million
Q3 2021 Nov 15, 2021	BUY	$13.71 - $17.18 $8.77 Million - $11 Million	639,887 New	639,887 $9.11 Million

Others Institutions Holding ORGO

# of Institutions

142

Shares Held

64.5M

Call Options Held

15.3K

Put Options Held

925

View Full List

About Organogenesis Holdings Inc.

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $377M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

More about ORGO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Soleus Capital Management, L.P. with notifications on news.

Account

Soleus Capital Management, L.P. Organogenesis Holdings Inc. Transaction History